Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hust

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Iscience|January 12, 2022
Immunity to SARS-CoV-2 up to 15 months after infectionHarold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
Nature Biotechnology|July 13, 2010
Minimum information about a protein affinity reagent (MIAPAR)Julie Bourbeillon, Sandra Orchard, Itai Benhar, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Hepatology (Baltimore, Md.)|September 2, 2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitisRichard Taubert, Bastian Engel, Jana Diestelhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2024
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineagesHarold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Iscience|January 12, 2022
Immunity to SARS-CoV-2 up to 15 months after infectionHarold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
Nature Biotechnology|July 13, 2010
Minimum information about a protein affinity reagent (MIAPAR)Julie Bourbeillon, Sandra Orchard, Itai Benhar, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Hepatology (Baltimore, Md.)|September 2, 2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitisRichard Taubert, Bastian Engel, Jana Diestelhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2024
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineagesHarold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 17